Fulminant myocarditis successfully treated with high-dose immunoglobulin

Hae Soon Kim, Sejung Sohn, Ji Yun Park, Jeong Wan Seo

Research output: Contribution to journalArticlepeer-review

19 Scopus citations


Fulminant myocarditis is characterized by the rapid development of life-threatening congestive heart failure. Intravenous immunoglobulin (IVIG), by modulating the immune response, may be used for the treatment of acute myocarditis. We report two children with fulminant myocarditis successfully treated with a 10-h infusion of high-dose IVIG. In those cases, a dramatic clinical improvement was achieved, with both cardiac enzymes and myocardial function normalized within 1-2 weeks after treatment.

Original languageEnglish
Pages (from-to)485-486
Number of pages2
JournalInternational Journal of Cardiology
Issue number3
StatePublished - Sep 2004


  • Immunoglobulin
  • Myocardits


Dive into the research topics of 'Fulminant myocarditis successfully treated with high-dose immunoglobulin'. Together they form a unique fingerprint.

Cite this